pSivida Corp. Stock Nasdaq

Stocks

16-08-09	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle	PU
16-07-14	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve	PU
16-05-02	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe	PU
15-09-28	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs	BU
15-09-14	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015	BU

1 day

-0.87%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
ARGENX SE	+0.08%	+0.50%	+57.69%	+108.83%	54.92B
WUXI APPTEC CO., LTD.	-0.34%	+3.51%	+45.55%	+40.16%	44.31B
BIONTECH SE	+0.29%	+6.20%	-14.80%	-19.65%	22.96B
INSMED INCORPORATED	-0.40%	+3.49%	-1.29%	+387.06%	21.12B
WUXI BIOLOGICS (CAYMAN) INC.	-2.91%	+0.27%	+13.28%	-36.73%	16.31B
GENMAB A/S	-1.02%	-2.33%	+6.68%	-41.24%	15.19B
EXELIXIS, INC.	-0.24%	+2.44%	+27.43%	+177.49%	13.32B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+1.48%	+9.81%	+19.29%	-	12.48B
PHARMAESSENTIA CORPORATION	+0.32%	+2.81%	+96.37%	+213.49%	11.21B
Average	-0.36%	+2.75%	+27.80%	+103.67%	23.54B
Weighted average by Cap.	-0.27%	+2.86%	+32.22%	+95.38%